You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ASCVD

Showing 1 - 25 of 257
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ASCVD, Coronary Artery Calcification Trial (Notification of patients and clinicians)

Not yet recruiting
  • ASCVD
  • Coronary Artery Calcification
  • Notification of patients and clinicians
  • (no location specified)
May 5, 2023

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

Not yet recruiting
  • ASCVD
  • +3 more
  • (no location specified)
Aug 3, 2023

Understand Real-world Awareness and Perceptions for Systemic

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease (ASCVD)
  • Chronic Kidney Disease (CKD)
  • No treatment given
  • Bangalore, India
    Novo Nordisk Investigational Site
Feb 23, 2023

sessmenT and treAtment In AustraliaN Primary Care

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease (ASCVD)
  • +3 more
  • Inclisiran Prefilled Syringe
  • Clayton, Victoria, Australia
    Monash Health
Apr 17, 2023

Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)

Not yet recruiting
  • Primary Hypercholesterolemia or Mixed Dyslipidemia
  • (no location specified)
May 24, 2023

Hypertension, Hyperlipidemias Trial (Penn Med Healthy Heart Program)

Not yet recruiting
  • Hypertension
  • Hyperlipidemias
  • Penn Med Healthy Heart Program
  • (no location specified)
Oct 2, 2023

Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)

Not yet recruiting
  • Coronary Artery Disease Progression
  • Intensive lipid-lowering control
  • Moderate-intensity lipid-lowering control
  • (no location specified)
Jul 13, 2022

Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Amman

Not yet recruiting
  • Dyslipidemias
  • Atherosclerotic Cardiovascular Disease
    • Amman, Jordan
    • +1 more
    Nov 23, 2022

    Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • +2 more
    • Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
    • Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
    • (no location specified)
    Mar 14, 2023

    ASCVD and Prediction Model

    Recruiting
    • Atherosclerosis
    • Prediction Model
      • Shanghai, China
      • +1 more
      Dec 6, 2021

      Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

      Recruiting
      • Type2Diabetes
      • ASCVD
      • SGLT2 inhibitor
      • +2 more
      • New York, New York
      • +1 more
      Dec 19, 2022

      Cardiovascular Diseases, Healthy Lifestyle, Health Education Trial in Hong Kong (HE programme, Usual care)

      Not yet recruiting
      • Cardiovascular Diseases
      • +2 more
      • HE programme
      • Usual care
      • Hong Kong, Hong Kong
        The Hong Kong Polytechnic University
      Jun 19, 2022

      Score Among Primary Health Care Centre Attendees, Assiut

      Not yet recruiting
      • Cardiovascular Risk Score
      • Framingham study cardiovascular disease 10-years risk assessment score
      • (no location specified)
      Aug 9, 2022

      Inclisiran Plus Standard of Care Lipid-lowering Therapy Compared

      Recruiting
      • Primary Hypercholesterolemia
      • Mixed Dyslipidemia
      • Inclisiran
      • Geneve 14, Switzerland
        Novartis Investigative Site
      Nov 14, 2022

      Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease

      Recruiting
      • Non-Alcoholic Fatty Liver Disease
      • Machine Learning
      • 10-year ASCVD risk estimation
      • Nanjing, Jiangsu, China
        Division of Endocrinology, the Affiliated Drum Tower Hospital of
      Sep 29, 2022

      Diabetes, Type 2, Cardiovascular Diseases Trial in Louisville (Educational Intervention)

      Active, not recruiting
      • Diabetes Mellitus, Type 2
      • Cardiovascular Diseases
      • Educational Intervention
      • Louisville, Kentucky
        Humana
      May 13, 2022

      Diabetes, Pre Diabetes, ASCVD Trial (high-intensity statin arm, low-intensity statin plus ezetimibe)

      Not yet recruiting
      • Diabetes Mellitus
      • +2 more
      • high-intensity statin arm
      • low-intensity statin plus ezetimibe
      • (no location specified)
      Oct 12, 2022

      Late Subclinical Cardiovascular Disease in Testicular Cancer

      Recruiting
      • Testicular Cancer
      • +7 more
      • Lipid profile
      • +2 more
      • Indianapolis, Indiana
        Indiana University
      Nov 7, 2022

      Hypercholesterolemia Trial in Worldwide (inclisiran sodium, Placebo)

      Active, not recruiting
      • Hypercholesterolemia
      • inclisiran sodium
      • Placebo
      • Lanzhou, Gansu, China
      • +44 more
      Feb 7, 2022

      ASCVD, Impaired Fasting Glucose, Hypertension Trial in Seongnam-si, Cheonan, Seoul (Duowell®, Monorova® + Amlopin®)

      Completed
      • ASCVD
      • +2 more
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
      • +3 more
      May 31, 2021

      The Learning Registry

      Enrolling by invitation
      • Atherosclerotic Cardiovascular Disease
        • Durham, North Carolina
          DCRI
        Dec 10, 2021

        Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density

        Active, not recruiting
        • Atherosclerotic Cardiovascular Disease
        • +2 more
        • Sale, Cheshire, United Kingdom
        • +16 more
        Jan 20, 2023

        Cardiovascular Diseases, Healthy Lifestyle, Health Education Trial (HE programme, Usual care)

        Not yet recruiting
        • Cardiovascular Diseases
        • +2 more
        • HE programme
        • Usual care
        • (no location specified)
        Aug 26, 2021

        Beauty From Within Community Screening Project

        Active, not recruiting
        • Heart Health Screening and Prevention
        • Fingerstick cholesterol test
        • +2 more
        • Los Angeles, California
          Cedars-Sinai Women's Heart Center
        Aug 13, 2021